PMWC 2017 Silicon Valley Session Themes AllClinical EnablementDx & RxEconomicsEmerging TechnologiesGenomic Data AnalysisGovernment and Private InitiativesHealthcare (Big) DataImmunotherapyInfectious DiseasesLiquid BiopsyMicrobiomeNext-Generation SequencingPatent Law & PoliciesPatient PerspectivesWellness How To Engage Community Oncologists in Precision Medicine Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair Companion Diagnostics: Where is the Incentive? Session Chair: Ed Winnick, GenomeWeb Immunotherapy: Emerging Applications and Therapies Session Chair: James Allison, MD Anderson Cancer Center Integrating Precision Medicine: Technical Challenges and Solutions Session Chair: Eric Dishman, NIH The Economics of Bringing Precision Medicine to the Clinic Session Chair: George Poste, ASU Genetic Testing In Healthy Population Session Chair: Randy Scott, Invitae The Secret to Wellness is Science Session Chair: Lee Hood, Providence Health Human Biospecimen Acquisition; Risks, Challenges and Solutions Session Chair: Matt McLoughlin, Scientist.com ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative Adoption of Precision Medicine: Hereditary Cancer Session Chair: Taylor Sittler, Color Genomics CIAPM: Accelerating Precision Medicine Advances in California Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM How to Commercialize Disruptive Technologies That Advance Precision Medicine Session Chair: Alex De Winter, GE Ventures Let’s talk mHealth And Telehealth And Their Impact On Our Lives Session Chair: Ida Sim, UCSF Tumor Profiling to Clinical Action Session Chair: Wolfgang Daum, Toma Biosciences Scaling the 26-Hour Genome Session Chair: Pieter van Rooyen, Edico Genome Patient Power: The Changing Role of Individuals Session Chair: Cliff Reid, Genos Research Progress in Improving the Evidence Base and Insurer Coverage Session Chair: Kathryn Phillips, UCSF Medical Devices and IoT: the Bridge to the Phenotype Session Chair: Sanjay Joshi, Dell EMC An Update on the Cancer Moonshot Blood Profiling Atlas Session Chair: Bruce Press, Seven Bridges An Update on the Cancer Moonshot and Brain Government Initiatives Session Chair: Joshua Gordon, National Institute of Mental Health Data Sharing: Patient Rights and Privacy Session Chair: William Knox Carey, Genecloud Enabling Advances in Human Microbiome Research Session Chair: Nick Conley, Epibiome Biobanking Your Future Session Chair: Nazneen Aziz, Kaiser Permanente Health Systems as Translational Research Partners Session Chair: Walter “Buzz” Stewart, Sutter Health How Molecular Subtyping Can Aid Clinical Drug Development Session Chair: Janusz Dutkowski, Data4Cure Precision Measurement in Biology Session Chair: Stephen Quake, Stanford University NGS: Implementing a Clinical Workflow for All Constituents Session Chair: Matthew Tindall, Omicia How Scientific Wellness Will Transform Healthcare Session Chair: Lee Hood, Providence Health Understanding Human Health and Diseases at the Individual Level Session Chair: Euan Ashley, Stanford Clinical Genomics Service Learnings from Precision Medicine Centers Session Chair: Berta Strulovici, Weizmann Institute How to Make Rx-Dx Alliances Work Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda The Value of Data Sharing Session Chair: John Leite, Illumina; John Shon, Illumina Population Precision Medicine Session Chair: Kirsten Bibbins-Domingo, UCSF Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges Session Chair: Walter Koch, Roche Personalized Medicine – The Cinderella Story of Venture Investments? Session Chair: Mara Aspinall, Genepeeks How Immuno-oncology Saved My Life: A Patient’s Perspective Session Chair: Andrew Schorr, Patient Power Developing Successful Predictive Clinical Biomarkers Session Chair: Ann Kapoun, Oncomed Achieving Accurate NGS Test Results Session Chair: Russell Garlick, SeraCare Clinical Trials in Immunotherapy Session Chair: Patrice Hugo, Q2 Solutions Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology Session Chair: Brad Gray, NanoString Technologies Generating Insights from Multi-modal Healthcare Data for Precision Medicine Session Chair: Atul Butte, UCSF Issues and Challenges of Immunotherapy Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care Session Chair: Assaf Halevy, 2bPrecise Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine Session Chair: John Ryals, Metabolon Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges Session Chair: Chris Cournoyer, N-of-One Unlocking Real-World Clinical Data Session Chair: Amy Abernethy, Flatiron Health Immunotherapy: Immunocheckpoint Inhibitors & Beyond Session Chair: Irv Weissman, Stanford School of Medicine Emerging Themes in the Human Microbiome Session Chair: Michael Fischbach, UCSF Expanding the Reach of Genomic Analysis Session Chair: Deanna Church, 10x Genomics Precision Medicine Patent Law Update Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West New Healthcare Paradigm from the $100 Genome Session Chair: Yiwu He, BGI Beyond Genomics for Predicting Patient Response Session Chair: Parker Cassidy, Mitra Biotech Building Value for Liquid Biopsies in Oncology Session Chair: Frederic Pla, Genomic Health Large Scale Human Genetics in Genomic Medicine and Drug Discovery Session Chair: Aris Baras, Regeneron Rare Disease Drug Development in Precision Medicine Session Chair: Mary Dixon Drake, Innovenn Clinical Next-Gen Sequencing for Infectious Disease Diagnosis Session Chair: Charles Chiu, UCSF Diagnostics Policy and the Impact on Innovation Session Chair: Michael W. Nall, Biocept Pathogen Specific Biologics for Infectious Diseases Session Chair: Steven J. Projan, Medimmune Importance of Standardized Assays for Precision Medicine Session Chair: Jeffrey Edward Miller, Invivoscribe Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy Session Chair: George Karlin-Neumann, BioRad Moving Precision Medicine to Precision Health Session Chair: Harold L. Paz, Aetna Clinical Applications of ctDNA in Cancer Management Session Chair: Clive Morris, Inivata Next-Generation Liquid Biopsy Testing: Promise and Limitations Session Chair: Jason Myers, ArcherDX Emerging Infections: Tracking, Testing and Public Health Response Session Chair: Steve Miller, UCSF Advancing the Clinic with Emerging NGS Technologies Session Chair: Allison Ballmer, RocheSee Program Schedule ->
